Analyzing the use of neuromuscular blocking agents in surgery
Clinical Practice Survey on the Management of Neuromuscular Blocking Agents and Their Antagonism During General Anesthesia
This study looks at how well doctors are following new guidelines for using muscle relaxants during surgery to see if it helps keep patients safer and improves their recovery.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Erasme University Hospital Academic / other |
| Locations | 1 site (Brussels) |
| Trial ID | NCT06238219 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the implementation of the 2023 recommendations from the American Society of Anesthesiologists (ASA) and the European Society of Anaesthesiology and Intensive Care (ESAIC) regarding neuromuscular blocking agents (NMBAs) during surgical procedures. By conducting a retrospective analysis at a single center, the study will assess how these guidelines are being followed in clinical practice. The focus is on understanding the management and antagonism of NMBAs to improve patient safety and outcomes during anesthesia.
Who should consider this trial
Good fit: Ideal candidates for this study are patients undergoing surgery that requires the use of neuromuscular blocking agents.
Not a fit: Patients who do not undergo surgery or those for whom neuromuscular blocking agents are not used will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the safety and effectiveness of anesthesia practices involving neuromuscular blocking agents.
How similar studies have performed: While this study focuses on the implementation of recent guidelines, similar studies have shown that adherence to established protocols can significantly improve patient outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: - All patients undergoing surgery with use of neuromuscular blocking agents at our institution Exclusion Criteria: - Incomplete electronic anesthesia record
Where this trial is running
Brussels
- Hôpital Universitaire de Bruxelles - Hôpital erasme — Brussels, Belgium (Recruiting)
Study contacts
- Study coordinator: Denis Schmartz, MD
- Email: denis.schmartz@hubruxelles.be
- Phone: +3225553919
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.